Skip to main content
Chatbot. It will open in a new tab
School of Science and Technology
Compare our programs. It will open in a new tab
Any questions?Compare our programs
Find your program. It will open in a new tab
Not sure what to study?Find your program
A circular shape with a gradient effect transitioning from green to white.

GSK-IE Biopharma and AI Gateway

  • Home
  • Gsk-ie Biopharma And Ai Gateway
A group of professionals gathered for the GSK-IE Next Frontiers in Health Gateway Program.

ABOUT THE GATEWAY

The GSK – IE Biopharma and AI Gateway provides a comprehensive understanding of the pharmaceutical and healthcare sectors, with a focus on the integration of biopharma innovation and artificial intelligence. Students gain exposure to the entire drug development lifecycle, from discovery and preclinical testing to clinical trials, regulatory approval, commercialization, and patient access.

This gateway is an optional, interdisciplinary offering that students can pursue while completing their degree at IE University.

The image features a modern logo of GSK.

PARTNER COMPANY

GSK is a global biopharmaceutical company that focuses on researching, developing and manufacturing innovative medicines and vaccines.

The company operates in various therapeutic areas, including respiratory, immuno-inflammation, oncology and infectious diseases. With a rich history of scientific innovation and a focus on sustainable practices, GSK is dedicated to advancing medical solutions that address some of the world’s most pressing health challenges.

Developed in collaboration with GSK, this gateway integrates industry insights and real-world applications, ensuring a highly relevant and practical learning experience.

WHO IS IT FOR

  • This gateway is designed for students interested in building a career in the health-tech and pharmaceutical industries, equipping them with key skills in healthcare innovation.

  • It is open to undergraduate students (3rd and 4th year) and master’s students from IE School of Science and Technology, IE Business School, and IE Law School, with admission granted on a case-by-case basis.

OBJECTIVES

  • Understand the structure and dynamics of the healthcare and pharmaceutical industries.
  • Identify and evaluate key technologies in drug discovery, preclinical research, and clinical development.
  • Apply PK/PD principles, biostatistics, and AI/data science tools to solve real-world pharmaceutical and healthcare challenges.
  • Evaluate regulatory and ethical frameworks while designing market access, pricing, and commercialization strategies for drugs and vaccines.
  • Collaborate in teams to design and deliver an AI-driven solution for a real-world GSK challenge.

TIMELINE

1
Phase 1
2
Phase 2
3
Phase 3

Phase 1

October - December

Admissions process and final selection

1/3

LEARNING AREAS

Throughout the training sessions, students gain a comprehensive understanding of the following key topics in the biopharma and healthcare ecosystem, guided by GSK experts and IE University faculty.

  • An abstract image featuring overlapping smooth curves in shades of green.
  • A smooth, abstract design featuring shades of green blending together.
  • A smooth gradient of green tones blending harmoniously.

FINAL CHALLENGE

As a culmination of the gateway, students put their skills into practice by addressing real-world challenges in collaboration with GSK, selecting from the following options as the focus of their final projects.

  • Commercialization Challenges

    • Commercialization Challenges
    • Underdiagnosis in COPD
    • Diagnostic Inaccuracy in Multiple Myeloma
    • Sales Attribution Model for Hospital Drugs

  • Clinical Research Challenges

    • Patient Recruitment Barriers
    • Streamlining Regulatory Compliance
    • Data Integrity and Integration

  • Medical Challenges

    • Regulatory Strategy Without Population Representation
    • Pandemic Disruption in Clinical Development
    • High-Efficacy Drug with Dermatologic Risks

Student Projects